Health Care/Hospital
Antengene Announces Acceptance of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM
SHANGHAI and HONG KONG, Dec. 11, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs
NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") received a decision from the European Union Intellectual Property Office (EUIPO) today that it has revoked the counterfeiter U-BioMed's falsely registered AQUAGOLD® design, originally created and owned by Aquavit. ...
Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026
With the third wave of biosimilars in the spotlight during the forecast period, revenues from the sensory organs market will dominate growth, finds Frost & Sullivan SANTA CLARA, Calif., Dec. 11, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Access to New Therapy Areas to Drive Major Gr...
DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020...
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("...
MicroPort CRM initiates a clinical trial for breakthrough innovative left ventricular lead Axone(TM)
PARIS, Dec. 10, 2020 /PRNewswire/ -- MicroPort Cardio Rhythm Management (CRM) has announced the first enrollment in the Astral-4LV clinical trial[1] to evaluate the safety and efficiency of Axone™, a breakthrough innovative quadripolar left ventricular lead. Axone™ is designed for use in heart fa...
Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
BEIJING, Dec. 10, 2020 /PRNewswire/ -- A statement on strengthening media cooperation issued by China Media Group (CMG) and its European media partners, calling on the Chinese and European media to fulfill their responsibilities as public information disseminators and jointly help the internat...
Cigna Study Shows Hong Kong's Overall Well-being Index Continues to Drop during the COVID-19 Pandemic
HONG KONG, Dec. 10, 2020 /PRNewswire/ -- Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's annual 360 Well-Being Survey, this research is the third in a series of studies to better understand the impact of...
ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System
PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study...
Nippon Express Korea Receives ISO 13485 Certification of Compliance with International Standard for Medical Device Quality Management Systems
TOKYO, Dec. 10, 2020 /PRNewswire/ -- Nippon Express Korea Co., Ltd. (hereinafter "NE Korea"), a local subsidiary of Nippon Express Co., Ltd., last month obtained ISO 13485 certification of compliance with the ISO standard for medical device quality management systems at its business location at I...
InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization
BOULDER, Colo., Dec. 10, 2020 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike ...
New Travel Health and Safety Protocols Implemented in Bali to Welcome Back Global Visitors
JAKARTA, Indonesia, Dec. 10, 2020 /PRNewswire/ -- Having seen an increase numbers of tourists, The Ministry of Tourism and Creative Economy (MoTCE) of Indonesia has made massive strides to ensure a safe Cleanliness, Health, Safety, and Environmental Sustainability (CHSE) protocols inBali. Namely ...
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world
Gates Foundation pledges additional $250 million to accelerate development and equitable distribution of COVID-19 tests, treatments, and vaccines to end the pandemic SEATTLE, Dec. 10, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced it will commit an additional$250 millio...
Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG
SYDNEY, Dec. 10, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clinical trial of...
Beijing Forum 2020 shines a spotlight on new challenges and opportunities of globalization
BEIJING, Dec. 10, 2020 /PRNewswire/ -- The Beijing Forum 2020 opened at Peking University onDecember 5, with bilingual live broadcasts across multiple platforms. This year, the international academic event, co-organized by Peking University, Beijing Municipal Education Commission, and Chey Instit...
Stellar Results from Kintor's GT90001 and Opdivo Combo Therapy in the Second-line Treatment of Advanced Liver Cancer: ORR Reached up to 40%
SHANGHAI, Dec. 10, 2020 /PRNewswire/ -- On December 9, 2020, Kintor Pharmaceutical Limited (HKEx: 9939) is pleased to announce that the Group has collected positive data in phase II clinical trials of combination therapy of ALK-1 (GT90001) antibody and PD-1 (Nivolumab or Opdivo) antibody for the ...
Cybernet on the Front Lines of Massive Vaccination Program
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- All eyes are on the United Kingdom today as they are the first western country in the world to begin to issue COVID-19 vaccinations. This ambitious undertaking, which has been dubbed the largest mass-vaccination program in the country's history, will ...
Sports Taping by 3NS, a Korean Kinesiology Tape Producer, Landing in Germany
BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- It is easy to see athletes taping their knees, thighs, ankles, and arms in various sports events such as marathon and basketball. The Kinesiology Tape has made steady progress since 1970 with the aim of preventing injuries and muscle pain to athletes...
3NS, a Korean Kinesiology Tape manufacturer, recommends effective use of sports tape
BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- Kinesiology Tape, a sports product and medical device that can prevent injuries and relieve pain with simple use, is drawing attention these days when home training is happening more often during this Pandemic. The Kinesiology Tape, a flexible sport...
Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an ORR of 70% in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
SUZHOU, China and ROCKVILLE, MD, Dec. 10, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced updates on the clinical devel...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00